While the above research tactics are useful, they are somewhat limited. For example, say a simple search reveals a competitor is starting trials in October 2020. Average trial and FDA approval timelines, combined with basic information extrapolated from the internet, might suggest an October 2025 launch.
However, this high-level search may not reveal that enrollment was completed early, bumping up the launch timeline to 2024. If you were preparing for a market contender entry in 2025, yet the competitor actually shows up in 2024, you may be unable to effectively counter to protect market share.
It’s this type of hidden data that working with an expert competitive intelligence team can uncover. At Two Labs, we have decades of experience conducting primary intelligence gathering and actively talking to industry, regulatory, and clinical sources to get valuable behind-the-scenes info. We customize our research for each client, asking the right questions to the right people to gain insights that can impact launch success. This gives our clients access to information others simply don’t have – a clear advantage come launch time.